메뉴 건너뛰기




Volumn 29, Issue 2, 2013, Pages 175-182

Vesicular stomatitis virus in the fight against cancer;Le virus de la stomatite vésiculaire dans la lutte contre le cancer

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLYTIC VIRUS;

EID: 84874712759     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2013292015     Document Type: Article
Times cited : (5)

References (57)
  • 1
    • 0000163167 scopus 로고    scopus 로고
    • Rhabdoviridae: The viruses and their replication
    • Knipe DM, Howley PM, eds Philadelphia: Lippincott Williams and Wilkins
    • Rose JK, Whitt MA. Rhabdoviridae: the viruses and their replication. In : Knipe DM, Howley PM, eds. Field's virology, vol. 1. Philadelphia: Lippincott Williams and Wilkins, 2001 : 1221-44.
    • (2001) Field's Virology, Vol. 1 , pp. 1221-1244
    • Rose, J.K.1    Whitt, M.A.2
  • 4
    • 77957744509 scopus 로고    scopus 로고
    • Distinct structural rearrangements of the VSV glycoprotein drive membrane fusion
    • Libersou S, Albertini AAV, Ouldali M, et al. Distinct structural rearrangements of the VSV glycoprotein drive membrane fusion. J Cell Biol 2010; 191 : 199-210.
    • (2010) J Cell Biol , vol.191 , pp. 199-210
    • Libersou, S.1    Albertini, A.A.V.2    Ouldali, M.3
  • 5
    • 66349113767 scopus 로고    scopus 로고
    • Vesicular stomatitis virus enters cells through vesicles incompletely coated with clathrin that depend upon actin for internalization
    • Cureton DK, Massol RH, Saffarian S, et al. Vesicular stomatitis virus enters cells through vesicles incompletely coated with clathrin that depend upon actin for internalization. PLoS Pathog 2009; 5 : e1000394.
    • (2009) PLoS Pathog , vol.5
    • Cureton, D.K.1    Massol, R.H.2    Saffarian, S.3
  • 6
  • 7
    • 33846959065 scopus 로고    scopus 로고
    • Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G
    • Roche S, Rey FA, Gaudin Y, Bressanelli S. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science 2007; 315 : 843-8.
    • (2007) Science , vol.315 , pp. 843-848
    • Roche, S.1    Rey, F.A.2    Gaudin, Y.3    Bressanelli, S.4
  • 9
    • 37849012529 scopus 로고    scopus 로고
    • Role of intermolecular interactions of vesicular stomatitis virus nucleoprotein in RNA encapsidation
    • Zhang X, Green TJ, Tsao J, et al. Role of intermolecular interactions of vesicular stomatitis virus nucleoprotein in RNA encapsidation. J Virol 2008; 82 : 674-82.
    • (2008) J Virol , vol.82 , pp. 674-682
    • Zhang, X.1    Green, T.J.2    Tsao, J.3
  • 10
    • 0029913350 scopus 로고    scopus 로고
    • Complementation of M gene mutants of vesicular stomatitis virus by plasmid-derived M protein converts spherical extracellular particles into native bullet shapes
    • Lyles DS, McKenzie MO, Kaptur PE, et al. Complementation of M gene mutants of vesicular stomatitis virus by plasmid-derived M protein converts spherical extracellular particles into native bullet shapes. Virology 1996; 217 : 76-87.
    • (1996) Virology , vol.217 , pp. 76-87
    • Lyles, D.S.1    McKenzie, M.O.2    Kaptur, P.E.3
  • 11
    • 63249117741 scopus 로고    scopus 로고
    • Vesicular stomatitis virus matrix protein mutations that affect association with host membranes and viral nucleocapsids
    • Dancho B, McKenzie MO, Connor JH, Lyles DS. Vesicular stomatitis virus matrix protein mutations that affect association with host membranes and viral nucleocapsids. J Biol Chem 2009; 284 : 4500-9.
    • (2009) J Biol Chem , vol.284 , pp. 4500-4509
    • Dancho, B.1    McKenzie, M.O.2    Connor, J.H.3    Lyles, D.S.4
  • 12
    • 0024449251 scopus 로고
    • Distribution of M protein and nucleocapsid protein of vesicular stomatitis virus in infected cell plasma membranes
    • McCreedy BJJ, Lyles DS. Distribution of M protein and nucleocapsid protein of vesicular stomatitis virus in infected cell plasma membranes. Virus Res 1989; 14 : 189-205.
    • (1989) Virus Res , vol.14 , pp. 189-205
    • McCreedy, B.J.J.1    Lyles, D.S.2
  • 13
    • 0025238554 scopus 로고
    • Role of matrix protein in cytopathogenesis of vesicular stomatitis virus
    • Blondel D, Harmison GG, Schubert M. Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol 1990; 64 : 1716-25.
    • (1990) J Virol , vol.64 , pp. 1716-1725
    • Blondel, D.1    Harmison, G.G.2    Schubert, M.3
  • 14
    • 0028100460 scopus 로고
    • Interaction between tubulin and the viral matrix protein of vesicular stomatitis virus: Possible implications in the viral cytopathic effect
    • Melki R, Gaudin Y, Blondel D. Interaction between tubulin and the viral matrix protein of vesicular stomatitis virus: possible implications in the viral cytopathic effect. Virology 1994; 202 : 339-47.
    • (1994) Virology , vol.202 , pp. 339-347
    • Melki, R.1    Gaudin, Y.2    Blondel, D.3
  • 15
    • 0031662097 scopus 로고    scopus 로고
    • Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III
    • Ahmed M, Lyles DS. Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III. J Virol 1998; 72 : 8413-9.
    • (1998) J Virol , vol.72 , pp. 8413-8419
    • Ahmed, M.1    Lyles, D.S.2
  • 16
    • 0036785522 scopus 로고    scopus 로고
    • Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1
    • Connor JH, Lyles DS. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1. J Virol 2002; 76 : 10177-87.
    • (2002) J Virol , vol.76 , pp. 10177-10187
    • Connor, J.H.1    Lyles, D.S.2
  • 17
    • 0033761842 scopus 로고    scopus 로고
    • The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes
    • Petersen JM, Her LS, Varvel V, et al. The matrix protein of vesicular stomatitis virus inhibits nucleocytoplasmic transport when it is in the nucleus and associated with nuclear pore complexes. Mol Cell Biol 2000; 20 : 8590-601.
    • (2000) Mol Cell Biol , vol.20 , pp. 8590-8601
    • Petersen, J.M.1    Her, L.S.2    Varvel, V.3
  • 18
    • 10744223476 scopus 로고    scopus 로고
    • VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
    • Stojdl DF, Lichty BD, tenOever BR, et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 2003; 4 : 263-75
    • (2003) Cancer Cell , vol.4 , pp. 263-275
    • Stojdl, D.F.1    Lichty, B.D.2    Tenoever, B.R.3
  • 19
    • 33646555810 scopus 로고    scopus 로고
    • Type 1 Interferons and the virus-host relationship: A lesson in detente
    • Garcia-Sastre A, Biron CA. Type 1 Interferons and the virus-host relationship: A lesson in detente. Science 2006; 312 : 879-82.
    • (2006) Science , vol.312 , pp. 879-882
    • Garcia-Sastre, A.1    Biron, C.A.2
  • 20
    • 0037384982 scopus 로고    scopus 로고
    • Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis
    • Ahmed M, McKenzie MO, Puckett S, et al. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J Virol 2003; 77 : 4646-57.
    • (2003) J Virol , vol.77 , pp. 4646-4657
    • Ahmed, M.1    McKenzie, M.O.2    Puckett, S.3
  • 21
    • 76249126382 scopus 로고    scopus 로고
    • Cryo-EM model of the bullet-shaped vesicular stomatitis virus
    • Ge P, Tsao J, Schein S, et al. Cryo-EM model of the bullet-shaped vesicular stomatitis virus. Science 2010; 327 : 689-93.
    • (2010) Science , vol.327 , pp. 689-693
    • Ge, P.1    Tsao, J.2    Schein, S.3
  • 22
    • 78049408241 scopus 로고    scopus 로고
    • Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity
    • Hoffmann M, Wu Y-J, Gerber M, et al. Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity. J Gen Virol 2010; 91 : 2782-93.
    • (2010) J Gen Virol , vol.91 , pp. 2782-2793
    • Hoffmann, M.1    Wu, Y.-J.2    Gerber, M.3
  • 23
    • 73949087549 scopus 로고    scopus 로고
    • Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells
    • Wollmann G, Rogulin V, Simon I, et al. Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells. J Virol 2010; 84 : 1563-73.
    • (2010) J Virol , vol.84 , pp. 1563-1573
    • Wollmann, G.1    Rogulin, V.2    Simon, I.3
  • 24
    • 0023411239 scopus 로고
    • The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis
    • Francoeur AM, Poliquin L, Stanners CP. The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis. Virology 1987; 160 : 236-45.
    • (1987) Virology , vol.160 , pp. 236-245
    • Francoeur, A.M.1    Poliquin, L.2    Stanners, C.P.3
  • 25
    • 80052067233 scopus 로고    scopus 로고
    • Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: Potential for oncolytic virotherapy
    • Janelle V, Brassard F, Lapierre P, et al. Mutations in the glycoprotein of vesicular stomatitis virus affect cytopathogenicity: potential for oncolytic virotherapy. J Virol 2011; 85 : 6513-20.
    • (2011) J Virol , vol.85 , pp. 6513-6520
    • Janelle, V.1    Brassard, F.2    Lapierre, P.3
  • 26
    • 0035194166 scopus 로고    scopus 로고
    • Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus
    • Kopeky SA, WIillingham MC, Lyles DS. Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus. J Virol 2001; 75 : 12169-81.
    • (2001) J Virol , vol.75 , pp. 12169-12181
    • Kopeky, S.A.1    Wiillingham, M.C.2    Lyles, D.S.3
  • 27
    • 0036058020 scopus 로고    scopus 로고
    • Matrix protein mutations contribute to inefficient induction of apoptosis leading to persistent infection of human neural cells by vesicular stomatitis virus
    • Desforges M, Despars G, Bérard S, et al. Matrix protein mutations contribute to inefficient induction of apoptosis leading to persistent infection of human neural cells by vesicular stomatitis virus. Virology 2002; 295 : 63-73.
    • (2002) Virology , vol.295 , pp. 63-73
    • Desforges, M.1    Despars, G.2    Bérard, S.3
  • 28
    • 0034653696 scopus 로고    scopus 로고
    • Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth
    • Bateman A, Bullough F, Murphy S, et al. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res 2000; 60 : 1492-7.
    • (2000) Cancer Res , vol.60 , pp. 1492-1497
    • Bateman, A.1    Bullough, F.2    Murphy, S.3
  • 29
    • 0033692809 scopus 로고    scopus 로고
    • Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: Implications for gene therapy
    • Higuchi H, Bronk SF, Bateman A, et al. Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy. Cancer Res 2000; 60 : 6396-402.
    • (2000) Cancer Res , vol.60 , pp. 6396-6402
    • Higuchi, H.1    Bronk, S.F.2    Bateman, A.3
  • 30
    • 0141461410 scopus 로고    scopus 로고
    • A new genetic method to generate and isolate small, shortlived but highly potent dendritic cell-tumor cell hybrid vaccines
    • Phan V, Errington F, Cheong SC, et al. A new genetic method to generate and isolate small, shortlived but highly potent dendritic cell-tumor cell hybrid vaccines. Nat Med 2003; 9 : 1215-9.
    • (2003) Nat Med , vol.9 , pp. 1215-1219
    • Phan, V.1    Errington, F.2    Cheong, S.C.3
  • 31
    • 12644313241 scopus 로고    scopus 로고
    • Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells
    • Danen-Van Oorschot AA, Fischer DF, Grimbergen JM, et al. Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci USA 1997; 94 : 5843- 7.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 5843-5847
    • Danen-Van Oorschot, A.A.1    Fischer, D.F.2    Grimbergen, J.M.3
  • 32
    • 32544433725 scopus 로고    scopus 로고
    • Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent
    • Burek M, Maddika S, Burek CJ, et al. Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent. Oncogene 2005; 25 : 2213-22.
    • (2005) Oncogene , vol.25 , pp. 2213-2222
    • Burek, M.1    Maddika, S.2    Burek, C.J.3
  • 33
    • 0033929057 scopus 로고    scopus 로고
    • Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
    • Stojdl DF, Lichty B, Knowles S, et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 2000; 6 : 821-5.
    • (2000) Nat Med , vol.6 , pp. 821-825
    • Stojdl, D.F.1    Lichty, B.2    Knowles, S.3
  • 34
    • 0035005593 scopus 로고    scopus 로고
    • Different host-cell shutoff strategies related to the matrix protein lead to persistance of vesicular stomatitis virus mutants on fibroblast cells
    • Desforges M, Charron J, Bérard S, et al. Different host-cell shutoff strategies related to the matrix protein lead to persistance of vesicular stomatitis virus mutants on fibroblast cells. Virus Res 2001; 76 : 87-102.
    • (2001) Virus Res , vol.76 , pp. 87-102
    • Desforges, M.1    Charron, J.2    Bérard, S.3
  • 35
    • 0033646858 scopus 로고    scopus 로고
    • Vesicular stomatitis virus (VSV) therapy of tumors
    • Balachandran S, Barber GN. Vesicular stomatitis virus (VSV) therapy of tumors. IUBMB Life 2000; 50 : 135-8.
    • (2000) IUBMB Life , vol.50 , pp. 135-138
    • Balachandran, S.1    Barber, G.N.2
  • 36
    • 1642553650 scopus 로고    scopus 로고
    • Defective translational control facilitates vesicular stomatitis virus oncolysis
    • Balachandran S, Barber GN. Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell 2004; 5 : 51-65.
    • (2004) Cancer Cell , vol.5 , pp. 51-65
    • Balachandran, S.1    Barber, G.N.2
  • 38
    • 78650861433 scopus 로고    scopus 로고
    • VSV Oncolytic virotherapy in the B16 model depends upon intact MyD88 signaling
    • Wongthida P, Diaz RM, Galivo F, et al. VSV Oncolytic virotherapy in the B16 model depends upon intact MyD88 signaling. Mol Ther 2011; 19 : 150-8.
    • (2011) Mol Ther , vol.19 , pp. 150-158
    • Wongthida, P.1    Diaz, R.M.2    Galivo, F.3
  • 39
    • 34247577195 scopus 로고    scopus 로고
    • Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway
    • Georgel P, Jiang Z, Kunz S, et al. Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. Virology 2007; 362 : 304-13.
    • (2007) Virology , vol.362 , pp. 304-313
    • Georgel, P.1    Jiang, Z.2    Kunz, S.3
  • 40
    • 63149198344 scopus 로고    scopus 로고
    • Vesicular stomatitis virus M protein mutant stimulates maturation of Toll-like receptor 7 (TLR7)-positive dendritic cells through TLR-dependent and -independent mechanisms
    • Ahmed M, Mitchell LM, Puckett S, et al. Vesicular stomatitis virus M protein mutant stimulates maturation of Toll-like receptor 7 (TLR7)-positive dendritic cells through TLR-dependent and -independent mechanisms. J Virol 2009; 83 : 2962-75.
    • (2009) J Virol , vol.83 , pp. 2962-2975
    • Ahmed, M.1    Mitchell, L.M.2    Puckett, S.3
  • 41
    • 0001511115 scopus 로고
    • Influence of complicating diseases upon leukemia
    • Dock G. Influence of complicating diseases upon leukemia. Am J Med Sci 1904; 127 : 563-92.
    • (1904) Am J Med Sci , vol.127 , pp. 563-592
    • Dock, G.1
  • 42
    • 84860868454 scopus 로고    scopus 로고
    • Apprivoiser nos ennemis pour en faire des alliés : la « virothérapie » anticancéreuse
    • Lemay G. Apprivoiser nos ennemis pour en faire des alliés : la « virothérapie » anticancéreuse. Med Sci (Paris) 2012; 28 : 339-40.
    • (2012) Med Sci (Paris) , vol.28 , pp. 339-340
    • Lemay, G.1
  • 43
    • 73949083187 scopus 로고    scopus 로고
    • Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting
    • Kelly EJ, Nace R, Barber GN, Russell SJ. Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J Virol 2010; 84 : 1550-62.
    • (2010) J Virol , vol.84 , pp. 1550-1562
    • Kelly, E.J.1    Nace, R.2    Barber, G.N.3    Russell, S.J.4
  • 44
    • 38049051428 scopus 로고    scopus 로고
    • Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy
    • Qiao J, Kottke T, Willmon C, et al. Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nat Med 2008; 14 : 37-44.
    • (2008) Nat Med , vol.14 , pp. 37-44
    • Qiao, J.1    Kottke, T.2    Willmon, C.3
  • 45
    • 68649104639 scopus 로고    scopus 로고
    • Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus
    • Doronin K, Shashkova EV, May SM, et al. Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus. Hum Gene Ther 2009; 20 : 975-88.
    • (2009) Hum Gene Ther , vol.20 , pp. 975-988
    • Doronin, K.1    Shashkova, E.V.2    May, S.M.3
  • 46
    • 84862017441 scopus 로고    scopus 로고
    • Recruitment of histone deacetylase 3 to the interferon-A gene promoters attenuates interferon expression
    • Génin P, Lin R, Hiscott J, Civas A. Recruitment of histone deacetylase 3 to the interferon-A gene promoters attenuates interferon expression. PLoS One 2012; 7 : e38336.
    • (2012) PLoS One , vol.7
    • Génin, P.1    Lin, R.2    Hiscott, J.3    Civas, A.4
  • 47
    • 33748088164 scopus 로고    scopus 로고
    • Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
    • Fulci G, Breymann L, Gianni D, et al. Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proc Natl Acad Sci USA 2006; 103 : 12873-8.
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 12873-12878
    • Fulci, G.1    Breymann, L.2    Gianni, D.3
  • 48
    • 77951987824 scopus 로고    scopus 로고
    • Synergistic interaction between oncolytic viruses augments tumor killing
    • Le Boeuf F, Diallo J-S, McCart JA, et al. Synergistic interaction between oncolytic viruses augments tumor killing. Mol Ther 2010; 18 : 888-95.
    • (2010) Mol Ther , vol.18 , pp. 888-895
    • Le Boeuf, F.1    Diallo, J.-S.2    McCart, J.A.3
  • 49
    • 41949096891 scopus 로고    scopus 로고
    • Oncolytic virotherapy: Molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses
    • Guo ZS, Thorne SH, Bartlett DL. Oncolytic virotherapy: Molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses. Biochim Biophys Acta 2008 ; 1785 : 217-31.
    • (2008) Biochim Biophys Acta , vol.1785 , pp. 217-231
    • Guo, Z.S.1    Thorne, S.H.2    Bartlett, D.L.3
  • 50
    • 0037089551 scopus 로고    scopus 로고
    • Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype
    • Fu X, Zhang X. Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype. Cancer Res 2002; 62 : 2306-12.
    • (2002) Cancer Res , vol.62 , pp. 2306-2312
    • Fu, X.1    Zhang, X.2
  • 51
    • 58849107795 scopus 로고    scopus 로고
    • Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: An overview
    • Msaouel P, Dispenzieri A, Galanis E. Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview. Curr Opin Mol Ther 2009; 11 : 43-53.
    • (2009) Curr Opin Mol Ther , vol.11 , pp. 43-53
    • Msaouel, P.1    Dispenzieri, A.2    Galanis, E.3
  • 52
    • 0037033736 scopus 로고    scopus 로고
    • ONYX-015: Mechanisms of action and clinical potential of a replication-selective adenovirus
    • Ries S, Korn WM. ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus. Br J Cancer 2002; 86 : 5-11.
    • (2002) Br J Cancer , vol.86 , pp. 5-11
    • Ries, S.1    Korn, W.M.2
  • 53
    • 80052406557 scopus 로고    scopus 로고
    • Intravenous delivery of a multimechanistic cancer-targeted oncolytic poxvirus in humans
    • Breitbach CJ, Burke J, Jonker D, et al. Intravenous delivery of a multimechanistic cancer-targeted oncolytic poxvirus in humans. Nature 2011; 477 : 99-102.
    • (2011) Nature , vol.477 , pp. 99-102
    • Breitbach, C.J.1    Burke, J.2    Jonker, D.3
  • 55
    • 84867027824 scopus 로고    scopus 로고
    • Phase II trial of intravenous administration of reolysin[reg] (Reovirus serotype-3-dearing strain) in patients with metastatic melanoma
    • Galanis E, Markovic SN, Suman VJ, et al. Phase II trial of intravenous administration of reolysin[reg] (Reovirus serotype-3-dearing strain) in patients with metastatic melanoma. Mol Ther 2012; 20 : 1998-2003.
    • (2012) Mol Ther , vol.20 , pp. 1998-2003
    • Galanis, E.1    Markovic, S.N.2    Suman, V.J.3
  • 56
    • 33947509571 scopus 로고    scopus 로고
    • La calréticuline détermine l'immunogénicité de la chimiothérapie et de la radiothérapie antitumorales
    • Apetoh L, Ghiringelli F, Zitvogel L. La calréticuline détermine l'immunogénicité de la chimiothérapie et de la radiothérapie antitumorales. Med Sci (Paris) 2007; 23 : 257-8.
    • (2007) Med Sci (Paris) , vol.23 , pp. 257-258
    • Apetoh, L.1    Ghiringelli, F.2    Zitvogel, L.3
  • 57
    • 84874713335 scopus 로고    scopus 로고
    • Stratégies génétiques, immunologiques et pharmacologiques au service d'une nouvelle génération de virus anticancéreux
    • Pol J, Le Boeuf F, Diallo JS. Stratégies génétiques, immunologiques et pharmacologiques au service d'une nouvelle génération de virus anticancéreux. Med Sci (Paris) 2013 : s29.
    • (2013) Med Sci (Paris)
    • Pol, J.1    Le Boeuf, F.2    Diallo, J.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.